Abstract
Cancer patients are vulnerable to COVID-19 with consequences on treatment delays and on mortality rate. This Comment explores the interaction between COVID-19 and cancer with attention paid to the modulation by cancer treatments of both ADAM17 and TMPRSS2, the proteases which control ACE2 processing, the SARS-CoV-2 target.
Cite
CITATION STYLE
APA
Brest, P., Mograbi, B., Hofman, P., & Milano, G. (2021, April 12). More light on cancer and COVID-19 reciprocal interaction. British Journal of Cancer. Springer Nature. https://doi.org/10.1038/s41416-020-01246-0
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free